Cargando…
A Lanthanum-Tagged Chemotherapeutic Agent HA-Pt to Track the In Vivo Distribution of Hyaluronic Acid Complexes
Hyaluronic acid drug conjugates can target anti-cancer drugs directly to tumor tissue for loco-regional treatment with enhanced bioavailability, local efficacy and reduced toxicity. In this study, the distribution and pharmacokinetics of hyaluronic acid carrier and a conjugated cisplatin anti-cancer...
Autores principales: | Zhang, Ti, Yang, Qiuhong, Forrest, W.C., Cai, Shuang, Aires, Daniel, Forrest, M. Laird |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706177/ https://www.ncbi.nlm.nih.gov/pubmed/26756040 |
Ejemplares similares
-
Implantable hyaluronic acid-deferoxamine conjugate prevents nonunions through stimulation of neovascularization
por: Donneys, Alexis, et al.
Publicado: (2019) -
Impact of Molecular Weight on Lymphatic Drainage of a Biopolymer-Based Imaging Agent
por: Bagby, Taryn R., et al.
Publicado: (2012) -
Injectable Chemotherapy Downstaged Oral Squamous Cell Carcinoma from Nonresectable to Resectable in a Rescue Dog: Diagnosis, Treatment, and Outcome
por: Cai, Shuang, et al.
Publicado: (2018) -
Use of Hyaluronic Acid (HA) in Chronic Airway Diseases
por: Máiz Carro, Luis, et al.
Publicado: (2020) -
Diagnosis: Benign bowel distribution of lanthanum carbonate
por: Wu, Hsin-Chi, et al.
Publicado: (2008)